VNA
CVS icon

Valley National Advisers’s CVS Health CVS Stock Holding History

Valley National Advisers’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Sell
1,483
-36
-2% -$2.77K 0.01% 312
2025
Q4 		$120K Buy
1,519
+52
+4% +$4.1K 0.02% 293
2025
Q3 		$110K Sell
1,467
-719
-33% -$49.3K 0.02% 288
2025
Q2 		$150K Sell
2,186
-286
-12% -$18.8K 0.02% 259
2025
Q1 		$167K Sell
2,472
-37
-1% -$2.21K 0.03% 244
2024
Q4 		$112K Sell
2,509
-2,150
-46% -$121K 0.02% 270
2024
Q3 		$292K Sell
4,659
-1,275
-21% -$74.4K 0.05% 204
2024
Q2 		$350K Sell
5,934
-18,762
-76% -$1.17M 0.05% 189
2024
Q1 		$1.97M Sell
24,696
-1,576
-6% -$120K 0.3% 70
2023
Q4 		$2.07M Sell
26,272
-371
-1% -$26.4K 0.33% 64
2023
Q3 		$1.86M Sell
26,643
-611
-2% -$43.3K 0.32% 65
2023
Q2 		$1.89M Sell
27,254
-2,801
-9% -$199K 0.32% 64
2023
Q1 		$2.21M Sell
30,055
-1,279
-4% -$107K 0.39% 54
2022
Q4 		$2.81M Sell
31,334
-786
-2% -$75.8K 0.5% 47
2022
Q3 		$2.95M Sell
32,120
-195
-0.6% -$19.3K 0.62% 43
2022
Q2 		$3.03M Sell
32,315
-299
-0.9% -$29.2K 0.64% 36
2022
Q1 		$3.3M Buy
32,614
+304
+0.9% +$31.9K 0.63% 36
2021
Q4 		$3.33M Buy
32,310
+475
+1% +$43.9K 0.61% 32
2021
Q3 		$2.7M Sell
31,835
-3,129
-9% -$262K 0.49% 42
2021
Q2 		$2.92M Buy
34,964
+26
+0.1% +$2.13K 0.53% 33
2021
Q1 		$2.63M Sell
34,938
-1,197
-3% -$87.2K 0.51% 34
2020
Q4 		$2.47M Sell
36,135
-907
-2% -$59K 0.52% 34
2020
Q3 		$2.16M Sell
37,042
-1,986
-5% -$124K 0.5% 34
2020
Q2 		$2.54M Sell
39,028
-1,067
-3% -$67.2K 0.58% 28
2020
Q1 		$2.38M Buy
40,095
+757
+2% +$50.5K 0.66% 30
2019
Q4 		$2.92M Sell
39,338
-6,597
-14% -$463K 0.73% 33
2019
Q3 		$2.9M Buy
45,935
+924
+2% +$54.8K 0.79% 32
2019
Q2 		$2.45M Sell
45,011
-216
-0.5% -$11.6K 0.67% 37
2019
Q1 		$2.44M Sell
45,227
-1,101
-2% -$68K 0.7% 36
2018
Q4 		$3.04M Sell
46,328
-852
-2% -$63.6K 0.98% 24
2018
Q3 		$3.71M Sell
47,180
-330
-0.7% -$23.6K 1.29% 18
2018
Q2 		$3.06M Buy
47,510
+682
+1% +$44.9K 1.17% 27
2018
Q1 		$2.91M Buy
46,828
+17,187
+58% +$1.23M 1.08% 24
2017
Q4 		$2.15M Buy
29,641
+14,249
+93% +$1.04M 0.75% 31
2017
Q3 		$1.25M Buy
15,392
+12,747
+482% +$1.01M 0.43% 44
2017
Q2 		$213K Buy
2,645
+949
+56% +$74.9K 0.08% 142
2017
Q1 		$133K Buy
1,696
+48
+3% +$3.83K 0.05% 165
2016
Q4 		$130K Buy
1,648
+2
+0.1% +$162 0.06% 168
2016
Q3 		$146K Sell
1,646
-144
-8% -$13.6K 0.08% 143
2016
Q2 		$171K Buy
1,790
+9
+0.5% +$897 0.09% 139
2016
Q1 		$185K Buy
1,781
+244
+16% +$23.7K 0.1% 134
2015
Q4 		$150K Buy
1,537
+1
+0.1% +$98 0.09% 139
2015
Q3 		$148K Buy
1,536
+1
+0.1% +$105 0.09% 140
2015
Q2 		$161K Buy
1,535
+346
+29% +$35.4K 0.09% 147
2015
Q1 		$123K Buy
1,189
+286
+32% +$28.9K 0.07% 151
2014
Q4 		$65K Buy
+903
New +$79.6K 0.05% 149

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Valley National Advisers's CVS Position: Q1 2026 in Review

Valley National Advisers reduced its CVS Health (CVS) stake by 2.4% in Q1 2026, selling an estimated $2.77K and leaving 1,483 shares worth $106K. The position accounts for 0.01% of the portfolio, ranked #312.

Valley National Advisers first reported a position in CVS in Q4 2014 and has held it in 46 quarters since. The position peaked at $3.71M in Q3 2018. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Valley National Advisers held 1,483 shares of CVS Health worth $106K as of Q1 2026.
  • Valley National Advisers sold 36 CVS Health shares in Q1 2026, an estimated $2.77K.
  • CVS Health made up 0.01% of Valley National Advisers's portfolio in Q1 2026, its #312 holding.
  • Valley National Advisers first reported a position in CVS Health in Q4 2014 and has held it in 46 quarters since.
  • Valley National Advisers's CVS Health position peaked at $3.71M in Q3 2018.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Valley National Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.